Senior Partner, Hector MacKay-Dunn, presented the Deal of the Year Award to Dr. Lawrence Mayer at the 19th Annual LifeSciences BC Awards held on April 19th.

This award honours the deal of the year which demonstrated excellence in mergers and acquisitions while bringing innovation to life in the BC Bioeconomy and beyond. Dr. Mayer, Co-Founder, President and Chief Scientific Officer lead the acquisition of Celator Pharmaceuticals Inc. by Jazz Pharmaceuticals in a cash deal valued at approximately USD $ 1.5 Billion, to access investigational product development for treating acute myeloid leukemia.

Photos of the award presentation: